International Stem Cell Corporation
ISCO
$0.115
$0.02527.78%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.53M | 8.32M | 7.83M | 7.79M | 8.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.53M | 8.32M | 7.83M | 7.79M | 8.33M |
| Cost of Revenue | 3.64M | 3.44M | 3.24M | 3.18M | 3.45M |
| Gross Profit | 4.89M | 4.88M | 4.59M | 4.61M | 4.88M |
| SG&A Expenses | 5.12M | 5.15M | 5.19M | 5.06M | 4.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.07M | 8.87M | 8.68M | 8.45M | 8.51M |
| Operating Income | -543.00K | -550.00K | -843.00K | -663.00K | -178.00K |
| Income Before Tax | -678.00K | -684.00K | -311.00K | -131.00K | 350.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.68 | -0.68 | -0.31 | -0.13 | 0.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -678.00K | -684.00K | -311.00K | -131.00K | 350.00K |
| EBIT | -543.00K | -550.00K | -843.00K | -663.00K | -178.00K |
| EBITDA | -343.00K | -356.00K | -651.00K | -469.00K | 20.00K |
| EPS Basic | -0.07 | -0.07 | -0.05 | -0.03 | 0.01 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.08 | -0.06 | -0.02 |
| EPS Diluted | -0.08 | -0.08 | -0.05 | -0.03 | 0.01 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.08 | -0.06 | -0.02 |
| Average Basic Shares Outstanding | 32.02M | 32.02M | 32.02M | 32.02M | 32.02M |
| Average Diluted Shares Outstanding | 32.02M | 32.02M | 32.02M | 32.02M | 32.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
